Clincosm LogoSign in Get a demo

HIV-1-infection

Showing 26 - 50 of 230
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hiv, HIV-1-infection Trial in Buenos Aires (Lamivudine 300 MG, Emtricitabine / Tenofovir Disoproxil Pill)

Active, not recruiting
  • Hiv
  • HIV-1-infection
  • Lamivudine 300 MG
  • Emtricitabine / Tenofovir Disoproxil Pill
  • Buenos Aires, Argentina
    Fundacion IDEAA
Jan 2, 2023

Quantification of Antisense HIV RNA in Patients

Recruiting
  • HIV-1-infection
  • Blood sampling
  • Paris, France
    Jean-Paul VIARD
Dec 21, 2022

HIV-1-infection Trial in Worldwide (Once daily CAB tablet + RPV tablet, Long acting CAB injectable + long acting RPV injectable)

Not yet recruiting
  • HIV-1-infection
  • Once daily CAB tablet + RPV tablet
  • Long acting CAB injectable + long acting RPV injectable
  • Atlanta, Georgia
  • +11 more
Dec 13, 2022

HIV Transmission in Era of Scaling up Antiretroviral Therapy in

Recruiting
  • HIV-1-infection
  • Antiretroviral Therapy
  • Exposure to antiretroviral therapy
  • Ādama, Oromia, Ethiopia
    Public hospitals and health centers in the Adama uptake area
Dec 15, 2022

HIV-1-infection, Adiposity, Insulin Resistance Trial in Brazil, United States (Semaglutide)

Active, not recruiting
  • HIV-1-infection
  • +4 more
  • Birmingham, Alabama
  • +7 more
Dec 7, 2022

HIV-1-infection Trial in Edmonton (B/F/TAF, Atripla, B/F/TAF Placebo)

Terminated
Has Results
  • HIV-1-infection
  • Edmonton, Alberta, Canada
    University of Alberta
Nov 21, 2022

oPtimize ANtiretroviral regimeNs in HIV-infected Women Who wAnt

Not yet recruiting
  • HIV-1-infection
  • Therapeutic drug monitoring in plasma of mother and child and in breastmilk
  • (no location specified)
Nov 29, 2022

HIV-1-infection Trial in Lesotho, Tanzania (Clinical management informed by HIV-1 genotypic resistance testing)

Active, not recruiting
  • HIV-1-infection
  • Clinical management informed by HIV-1 genotypic resistance testing
  • Seboche, Butha-Buthe, Lesotho
  • +9 more
Dec 4, 2022

HIV-1-infection Trial in Ghent (Dual versus triple therapy in treatment of HIV-1 infection.)

Recruiting
  • HIV-1-infection
  • Dual versus triple therapy in treatment of HIV-1 infection.
  • Ghent, Belgium
    Ghent University Hospital
Dec 5, 2022

HIV-1-infection, Adherence, Medication, Depression Trial in Nairobi (Vijana-SMART)

Completed
  • HIV-1-infection
  • +2 more
  • Vijana-SMART
  • Nairobi, Kenya
    Kayole
Nov 21, 2022

HIV-1-infection Trial in Shanghai, Kunming, Hangzhou (B/F/TAF, TDF-based triple ART regimen switching to B/F/TAF)

Recruiting
  • HIV-1-infection
  • B/F/TAF
  • TDF-based triple ART regimen switching to B/F/TAF
  • Shanghai, Shanghai, China
  • +2 more
Dec 1, 2022

HIV-1-infection Trial in United States (CVC 150 mg, CVC 300 mg, Placebo for CVC 150 mg)

Not yet recruiting
  • HIV-1-infection
  • CVC 150 mg
  • +3 more
  • Los Angeles, California
  • +16 more
Nov 22, 2022

HIV-1-infection, HIV, HIV I Infection Trial (CAB + RPV)

Not yet recruiting
  • HIV-1-infection
  • +2 more
  • CAB + RPV
  • (no location specified)
Nov 16, 2022

HIV/AIDS, HIV-1-infection Trial in Durban (Point-of-care viral load testing and tenofovir adherence testing)

Recruiting
  • HIV/AIDS
  • HIV-1-infection
  • Point-of-care viral load testing and tenofovir adherence testing
  • Durban, KwaZulu-Natal, South Africa
    Centre for the AIDS Programme of Research in South Africa (CAPRI
Nov 16, 2022

HIV-1-infection Trial in Madrid (BIC/FTC/TAF: Bictegravir/emtricitabina/tenofovir alafenamida fumarato)

Completed
  • HIV-1-infection
  • BIC/FTC/TAF: Bictegravir/emtricitabina/tenofovir alafenamida fumarato
  • Madrid, Spain
    Hospital FUNDACIÓN JIMÉNEZ DÍAZ
Nov 2, 2022

HIV Vaccine, HIV-1-infection Trial in Chapel Hill, Durham (C62, C1C62, Placebo)

Recruiting
  • HIV Vaccine
  • HIV-1-infection
  • C62
  • +4 more
  • Chapel Hill, North Carolina
  • +1 more
Oct 27, 2022

Bictegravir in the Elderly Living With HIV (BICEP)

Active, not recruiting
  • HIV-1-infection
  • Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]
  • Buffalo, New York
    Evergreen Health
Oct 28, 2022

HIV-1-infection Trial in Puerto Rico, United States (TMB-365/TMB-380)

Recruiting
  • HIV-1-infection
  • San Francisco, California
  • +6 more
Oct 25, 2022

HIV-1-infection Trial in Butha-Buthe (Dolutegravir)

Active, not recruiting
  • HIV-1-infection
  • Butha-Buthe, Lesotho
  • +1 more
Oct 23, 2022

HIV-1-infection, Medication Adherence, Satisfaction, Patient Trial in Little Rock (Home visit delivery strategy)

Recruiting
  • HIV-1-infection
  • +2 more
  • Home visit delivery strategy
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Oct 20, 2022

HIV-1-infection Trial in San Francisco, Saint Louis, Camden (EBT-101)

Enrolling by invitation
  • HIV-1-infection
  • EBT-101
  • San Francisco, California
  • +2 more
Oct 17, 2022

HIV-1-infection Trial in Worldwide (Oral Lenacapavir, Oral Lenacapavir Placebo, Subcutaneous Lenacapavir)

Active, not recruiting
Has Results
  • HIV-1-infection
  • Oral Lenacapavir
  • +4 more
  • Los Angeles, California
  • +74 more
Oct 17, 2022

Immune Activation and Latent HIV Reservoir Size Between People

Enrolling by invitation
  • HIV-1-infection
  • +3 more
  • Venipuncture
  • +4 more
  • Seattle, Washington
    University of Washington Positive Research and the Gastroenterol
Oct 14, 2022

Pertussis Immunization During Pregnancy & HIV Infection

Completed
  • Immunization; Infection
  • +3 more
  • TDaP
  • Brussels, Belgium
  • +1 more
Sep 29, 2022

Health-related Quality of Life in HIV-1 Infected Adults

Active, not recruiting
  • HIV-1-infection
  • Montréal, Canada
  • +5 more
Sep 22, 2022